ACTRN12623000335695
Completed
未知
The Effect of Immunonutrition Supplements on Pressure Ulcers and Malnutrition Status among Spinal Cord Injury Patients Under Rehabilitation
niversiti Kebangsaan Malaysia0 sites18 target enrollmentMarch 31, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversiti Kebangsaan Malaysia
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The inclusion criteria were spinal cord injury patients with an outpatient appointment at the clinic with pressure ulcers stage II, III and IV (Black et al. 2007\), malnutrition or at\-risk of malnutrition, not diabetic, and able to communicate.
Exclusion Criteria
- •i) Patients with full nasogastric tube feeding
- •ii) Patients with pressure sores due to diabetic ulcers and trauma due to infection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effect of a special nutritional oral supplement use on inflammation in patients with COVID-19RBR-7jrxqmniversidade do Estado da Bahia
Not yet recruiting
Not Applicable
A clinical study to investigate the effects of oral immunonutrients during the perioperative period of patients with gastrointestinal cancerRBR-6sz8zhtniversidade do Estado da Bahia
Recruiting
Not Applicable
Effect of immunonutrient therapy on health status among liver disease patients waiting for liver transplantation- A Randomized Controlled TrialCTRI/2019/08/020973Jawaharlal Institute of postgraduate Medical Education Research
Completed
Not Applicable
A study for immunostimulatory effects of intake of spore-forming lactic acid bacteria in adult men and womeHealthy adultJPRN-UMIN000042937TTC Co., Ltd80
Completed
Not Applicable
The effect of a disease-specific supplement on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementatioDiabetes Mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetesISRCTN86065299umico Research B.V. (The Netherlands)34